AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE
To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | hrv ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PATEL, SACHEL V KEDDY, RYAN G HUTCHINS, CHARLES W CARROLL, WILLIAM A WAGAW, SEBEL H LIU, DACHUN DONNER, PAMELA L RANDOLPH, JOHN T ROCKWAY, TODD W GAO, YI KATI, WARREN M TUFANO, MICHAEL D HUTCHINSON, DOUGLAS K KRUEGER, ALLAN C FLENTGE, CHARLES A BETEBENNER, DAVID A BELLIZZI, MARY E JINKERSON, TAMMIE K SARRIS, KATHY MARING, CLARENCE J LI, WENKE DEGOEY, DAVID A WAGNER, ROLF CALIFANO, JEAN C CASPI, DANIEL D WOLLER, KEVIN R NELSON, LISSA T PRATT, JOHN K MOTTER, CHRISTOPHER E MATULENKO, MARK A |
| description | To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HRP20151389TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HRP20151389TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HRP20151389TT13</originalsourceid><addsrcrecordid>eNrjZHBx9FNw9AvxDPMMcvRRMNQN8HD1i_TRNdIx1XXxdHL1i_L09XRxjPL30TXVBYoHRAYF-ft4unj6uSq4uAZ5hjkCtbryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4j6AAIwNDU0NjC8uQEENj4lQBAPSzLRk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE</title><source>esp@cenet</source><creator>PATEL, SACHEL V ; KEDDY, RYAN G ; HUTCHINS, CHARLES W ; CARROLL, WILLIAM A ; WAGAW, SEBEL H ; LIU, DACHUN ; DONNER, PAMELA L ; RANDOLPH, JOHN T ; ROCKWAY, TODD W ; GAO, YI ; KATI, WARREN M ; TUFANO, MICHAEL D ; HUTCHINSON, DOUGLAS K ; KRUEGER, ALLAN C ; FLENTGE, CHARLES A ; BETEBENNER, DAVID A ; BELLIZZI, MARY E ; JINKERSON, TAMMIE K ; SARRIS, KATHY ; MARING, CLARENCE J ; LI, WENKE ; DEGOEY, DAVID A ; WAGNER, ROLF ; CALIFANO, JEAN C ; CASPI, DANIEL D ; WOLLER, KEVIN R ; NELSON, LISSA T ; PRATT, JOHN K ; MOTTER, CHRISTOPHER E ; MATULENKO, MARK A</creator><creatorcontrib>PATEL, SACHEL V ; KEDDY, RYAN G ; HUTCHINS, CHARLES W ; CARROLL, WILLIAM A ; WAGAW, SEBEL H ; LIU, DACHUN ; DONNER, PAMELA L ; RANDOLPH, JOHN T ; ROCKWAY, TODD W ; GAO, YI ; KATI, WARREN M ; TUFANO, MICHAEL D ; HUTCHINSON, DOUGLAS K ; KRUEGER, ALLAN C ; FLENTGE, CHARLES A ; BETEBENNER, DAVID A ; BELLIZZI, MARY E ; JINKERSON, TAMMIE K ; SARRIS, KATHY ; MARING, CLARENCE J ; LI, WENKE ; DEGOEY, DAVID A ; WAGNER, ROLF ; CALIFANO, JEAN C ; CASPI, DANIEL D ; WOLLER, KEVIN R ; NELSON, LISSA T ; PRATT, JOHN K ; MOTTER, CHRISTOPHER E ; MATULENKO, MARK A</creatorcontrib><description>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</description><language>hrv ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160115&DB=EPODOC&CC=HR&NR=P20151389T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160115&DB=EPODOC&CC=HR&NR=P20151389T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PATEL, SACHEL V</creatorcontrib><creatorcontrib>KEDDY, RYAN G</creatorcontrib><creatorcontrib>HUTCHINS, CHARLES W</creatorcontrib><creatorcontrib>CARROLL, WILLIAM A</creatorcontrib><creatorcontrib>WAGAW, SEBEL H</creatorcontrib><creatorcontrib>LIU, DACHUN</creatorcontrib><creatorcontrib>DONNER, PAMELA L</creatorcontrib><creatorcontrib>RANDOLPH, JOHN T</creatorcontrib><creatorcontrib>ROCKWAY, TODD W</creatorcontrib><creatorcontrib>GAO, YI</creatorcontrib><creatorcontrib>KATI, WARREN M</creatorcontrib><creatorcontrib>TUFANO, MICHAEL D</creatorcontrib><creatorcontrib>HUTCHINSON, DOUGLAS K</creatorcontrib><creatorcontrib>KRUEGER, ALLAN C</creatorcontrib><creatorcontrib>FLENTGE, CHARLES A</creatorcontrib><creatorcontrib>BETEBENNER, DAVID A</creatorcontrib><creatorcontrib>BELLIZZI, MARY E</creatorcontrib><creatorcontrib>JINKERSON, TAMMIE K</creatorcontrib><creatorcontrib>SARRIS, KATHY</creatorcontrib><creatorcontrib>MARING, CLARENCE J</creatorcontrib><creatorcontrib>LI, WENKE</creatorcontrib><creatorcontrib>DEGOEY, DAVID A</creatorcontrib><creatorcontrib>WAGNER, ROLF</creatorcontrib><creatorcontrib>CALIFANO, JEAN C</creatorcontrib><creatorcontrib>CASPI, DANIEL D</creatorcontrib><creatorcontrib>WOLLER, KEVIN R</creatorcontrib><creatorcontrib>NELSON, LISSA T</creatorcontrib><creatorcontrib>PRATT, JOHN K</creatorcontrib><creatorcontrib>MOTTER, CHRISTOPHER E</creatorcontrib><creatorcontrib>MATULENKO, MARK A</creatorcontrib><title>AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE</title><description>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBx9FNw9AvxDPMMcvRRMNQN8HD1i_TRNdIx1XXxdHL1i_L09XRxjPL30TXVBYoHRAYF-ft4unj6uSq4uAZ5hjkCtbryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4j6AAIwNDU0NjC8uQEENj4lQBAPSzLRk</recordid><startdate>20160115</startdate><enddate>20160115</enddate><creator>PATEL, SACHEL V</creator><creator>KEDDY, RYAN G</creator><creator>HUTCHINS, CHARLES W</creator><creator>CARROLL, WILLIAM A</creator><creator>WAGAW, SEBEL H</creator><creator>LIU, DACHUN</creator><creator>DONNER, PAMELA L</creator><creator>RANDOLPH, JOHN T</creator><creator>ROCKWAY, TODD W</creator><creator>GAO, YI</creator><creator>KATI, WARREN M</creator><creator>TUFANO, MICHAEL D</creator><creator>HUTCHINSON, DOUGLAS K</creator><creator>KRUEGER, ALLAN C</creator><creator>FLENTGE, CHARLES A</creator><creator>BETEBENNER, DAVID A</creator><creator>BELLIZZI, MARY E</creator><creator>JINKERSON, TAMMIE K</creator><creator>SARRIS, KATHY</creator><creator>MARING, CLARENCE J</creator><creator>LI, WENKE</creator><creator>DEGOEY, DAVID A</creator><creator>WAGNER, ROLF</creator><creator>CALIFANO, JEAN C</creator><creator>CASPI, DANIEL D</creator><creator>WOLLER, KEVIN R</creator><creator>NELSON, LISSA T</creator><creator>PRATT, JOHN K</creator><creator>MOTTER, CHRISTOPHER E</creator><creator>MATULENKO, MARK A</creator><scope>EVB</scope></search><sort><creationdate>20160115</creationdate><title>AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE</title><author>PATEL, SACHEL V ; KEDDY, RYAN G ; HUTCHINS, CHARLES W ; CARROLL, WILLIAM A ; WAGAW, SEBEL H ; LIU, DACHUN ; DONNER, PAMELA L ; RANDOLPH, JOHN T ; ROCKWAY, TODD W ; GAO, YI ; KATI, WARREN M ; TUFANO, MICHAEL D ; HUTCHINSON, DOUGLAS K ; KRUEGER, ALLAN C ; FLENTGE, CHARLES A ; BETEBENNER, DAVID A ; BELLIZZI, MARY E ; JINKERSON, TAMMIE K ; SARRIS, KATHY ; MARING, CLARENCE J ; LI, WENKE ; DEGOEY, DAVID A ; WAGNER, ROLF ; CALIFANO, JEAN C ; CASPI, DANIEL D ; WOLLER, KEVIN R ; NELSON, LISSA T ; PRATT, JOHN K ; MOTTER, CHRISTOPHER E ; MATULENKO, MARK A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HRP20151389TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>hrv ; eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PATEL, SACHEL V</creatorcontrib><creatorcontrib>KEDDY, RYAN G</creatorcontrib><creatorcontrib>HUTCHINS, CHARLES W</creatorcontrib><creatorcontrib>CARROLL, WILLIAM A</creatorcontrib><creatorcontrib>WAGAW, SEBEL H</creatorcontrib><creatorcontrib>LIU, DACHUN</creatorcontrib><creatorcontrib>DONNER, PAMELA L</creatorcontrib><creatorcontrib>RANDOLPH, JOHN T</creatorcontrib><creatorcontrib>ROCKWAY, TODD W</creatorcontrib><creatorcontrib>GAO, YI</creatorcontrib><creatorcontrib>KATI, WARREN M</creatorcontrib><creatorcontrib>TUFANO, MICHAEL D</creatorcontrib><creatorcontrib>HUTCHINSON, DOUGLAS K</creatorcontrib><creatorcontrib>KRUEGER, ALLAN C</creatorcontrib><creatorcontrib>FLENTGE, CHARLES A</creatorcontrib><creatorcontrib>BETEBENNER, DAVID A</creatorcontrib><creatorcontrib>BELLIZZI, MARY E</creatorcontrib><creatorcontrib>JINKERSON, TAMMIE K</creatorcontrib><creatorcontrib>SARRIS, KATHY</creatorcontrib><creatorcontrib>MARING, CLARENCE J</creatorcontrib><creatorcontrib>LI, WENKE</creatorcontrib><creatorcontrib>DEGOEY, DAVID A</creatorcontrib><creatorcontrib>WAGNER, ROLF</creatorcontrib><creatorcontrib>CALIFANO, JEAN C</creatorcontrib><creatorcontrib>CASPI, DANIEL D</creatorcontrib><creatorcontrib>WOLLER, KEVIN R</creatorcontrib><creatorcontrib>NELSON, LISSA T</creatorcontrib><creatorcontrib>PRATT, JOHN K</creatorcontrib><creatorcontrib>MOTTER, CHRISTOPHER E</creatorcontrib><creatorcontrib>MATULENKO, MARK A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PATEL, SACHEL V</au><au>KEDDY, RYAN G</au><au>HUTCHINS, CHARLES W</au><au>CARROLL, WILLIAM A</au><au>WAGAW, SEBEL H</au><au>LIU, DACHUN</au><au>DONNER, PAMELA L</au><au>RANDOLPH, JOHN T</au><au>ROCKWAY, TODD W</au><au>GAO, YI</au><au>KATI, WARREN M</au><au>TUFANO, MICHAEL D</au><au>HUTCHINSON, DOUGLAS K</au><au>KRUEGER, ALLAN C</au><au>FLENTGE, CHARLES A</au><au>BETEBENNER, DAVID A</au><au>BELLIZZI, MARY E</au><au>JINKERSON, TAMMIE K</au><au>SARRIS, KATHY</au><au>MARING, CLARENCE J</au><au>LI, WENKE</au><au>DEGOEY, DAVID A</au><au>WAGNER, ROLF</au><au>CALIFANO, JEAN C</au><au>CASPI, DANIEL D</au><au>WOLLER, KEVIN R</au><au>NELSON, LISSA T</au><au>PRATT, JOHN K</au><au>MOTTER, CHRISTOPHER E</au><au>MATULENKO, MARK A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE</title><date>2016-01-15</date><risdate>2016</risdate><abstract>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | hrv ; eng |
| recordid | cdi_epo_espacenet_HRP20151389TT1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AN ANTIVIRAL 1-PHENYL-2,5-DIBENZIMIDAZOL-5-YL-PYRROLIDINE DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PATEL,%20SACHEL%20V&rft.date=2016-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHRP20151389TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |